From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 12,096,900 shares, representing 0.87% for CNY 100.01 million under the buyback announced on January 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.54 CNY | -4.97% | -14.24% | -31.69% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.69% | 1.06B | |
+43.33% | 6.3B | |
-16.78% | 4.44B | |
-6.93% | 3.27B | |
+3.89% | 3.16B | |
-0.88% | 2.58B | |
+46.64% | 1.96B | |
-5.34% | 1.73B | |
+1.60% | 1.68B | |
-7.31% | 1.63B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.